Effects of polymerization on the hypertensive action of diaspirin cross-linked hemoglobin in rats

Journal of Laboratory and Clinical Medicine

Volumn 129, Issue 6, 1997, Pages 603-610

  Abassi, Zaid ^a,c   Kotob, Shaban ^a   Pieruzzi, Federico ^a   Abouassali, Majd ^a   Keiser, Harry R ^a   Fratantoni, Joseph C ^a   Alayash, Abdu I ^a,b  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^c RAMBAM MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0031170892     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(97)90194-3     Document Type: Article

References (25)

1. Vandegriff KD. Blood substitutes: Engineering the hemoglobin molecule. Biotechnol Genet Eng Rev 1992;10:403-53.
2. Winslow RM. Hemoglobin-based red cell substitutes. Baltimore: Johns Hopkins Press, 1992:98-117.
3. Hess JR, MacDonald VW, Brinkley WW. Systemic and pulmonary hypertension after resuscitation with cell-free hemoglobin. J Appl Physiol 1993;74:1769-78.
4. Sharma AC, Singh G, Gulati A. Role of NO mechanism in cardiovasular effects of diaspirin cross-linked hemoglobin in anesthetized rats. Am J Physiol 1995;38: H1379-H1388.
5. Freas W, Llave R, Jing M, Hart J, MaQuillan P, Maldoon S. Contractile effects of diaspirin cross-linked hemoglobin (DCLHbTM) on isolated porcine blood vessels. J Lab Med 1995;125:762-7.
6. Rogers MS, Brockner Ryan BA, Cashon RE, Alayash AI. Effects of polymerization on the redox and oxygen carrying properties of diaspirin cross-linked hemoglobin. Biochim Biophys Acta 1995;1248:135-42.
7. Blantz RC, Tucker BJ. Measurements of glomerular dynamics. In: Martinez-Maldonado M, editor. Methods of pharmacology: Renal pharmacology. New York: Plenum, 1978:141-63.
8. Zimmer HG, Zierhut W, Seesko RC, Varekamp AE. Right heart catheterization in rats with pulmonary hypertension and right ventricular hypertrophy. Basic Res Cardiol 1988; 83:43-57.
9. Abassi ZA, Kotob S, Golomb E, Pieruzzi F, Keiser RH. Pulmonary and renal neutral endopeptidase EC 3.4.24.11 in rats with experimental heart failure. Hypertension 1995; 25:1178-84.
10. Kida Y, Maeda M, Iwata S, Iwashita Y, Goto K, Nishi K. Effects of pyridoxalated hemoglobin polyoxyethylene conjugate and other hemoglobin-related substances on arterial blood pressure in anesthetized and conscious rats. Artif Organs 1995;19:117-28.
11. Gould SA, Sehgal LR, Sehgal H, Moss GS. The development of hemoglobin solutions as red cell substitutes: Hemoglobin solutions. Transfus Sci 1995;16:5-17.
12. Lee R, Neya K, Svizzero TA, Vlahakes GJ. Limitations of the efficacy of hemoglobin-based oxygen carrying solutions. J Appl Physiol 1995;78:236-42.
13. Lieberthal W, Wolf EF, Meril EW, Levinsky NS, Valeri CR. Hemodynamic effects of different preparations of stromafree hemolysates in the isolated perfused rat kidney. Life Sci 1987;41:2525-33.
14. Matheson-Urbaitis B, San Lu Y, Fronticelli C, Bucci E. Renal and systemic-hemodynamic response to isovolemic exchange transfusion with hemoglobin cross-linked with bis(3,5-dibromosalicyl) fumarate or albumin. J Lab Clin Med 1995;126:250-60.
15. Willinger CC, Schramek H, Pfaller K, Pfaller W, Deetjen P. Ultrapure polymerized bovine hemoglobin (UPPBHb) improves integrity of isolated perused rat kidney (IPRK): Effects on function and structure. Clin Nephrol 1995;44:32-43.
16. Balylis C, Harton P, Engles K. Endothelial derived relaxing factor controls renal hemodynamic in normal rat kidney. J Am Soc Nephrol 1990;1:875-81.
17. Schultz SC, Grady B, Hamilton I, Burhop K, Malcolm DS. A role for endothelin and nitric oxide in the pressor response to diaspirin cross-linked hemoglobin. J Lab Clin Med 1993;122: 301-08.
18. Gulati A, Rebello S. Role of adrenergic mechanisms in the pressor effect of diaspirin cross-linked hemoglobin. J Lab Clin Med 1994;124:125-33.
19. Tasi AB, Kreger H, Intaglietta M. Microvascular oxygen distribution: Effects due to hemoglobin in plasma. In: Winslow RM, Vandegriff KD, Intaglietta M, editors. Blood substitutes: New challenges. Boston: Birkhauser, 1996:124-31.
20. Malcolm DS, Hamilton IN, Schultz SC, Cole F, Burhop K. Characterization of the hemodynamic respose to intravenous diaspirin crosslinked hemoglobin solutions in rats. Artif Cells Blood Substit Immobil Biotechnol 1994;22:91-107.
21. Katsuyama SS, Cole DJ, Drummond JC, Bradley K. Nitric oxide mediates the hypertensive response to a modified hemoglobin solution (DCLHbTM ) in rats. Artif Cells Blood Substit Immobil Biotechnol 1994;22:l-7.
22. Blantz RC, Evan AP, Gabbai FB. Red cell substitutes in the kidney. In: Winslow RM, Vandegriff KD, Intaglietta M, editors. Blood substitutes: Physiological basis of efficacy. Boston: Birkhauser, 1995:123-42.
23. Huang PL, Huang Z, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA, et al. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 1995; 377:239-42.
24. Hess RJ. Hemoglobin polymerization for the prevention of vasoconstriction: A review of the relation between interstitial concentration for large molecules. Presented at the meeting on Current Issues in Blood Substitutes Research and Development, March 1996, San Diego, CA. Program and Abstract, 1996:45.
25. Mullane KM, Young M. The contribution of neutrophil activation and changes in endothelial function to myocardial-reperfusion injury. In: Yellon DM, Jennings R, editors. Myocardial protection: The pathophysiology of reper-fusion and reperfusion injury. New York: Raven Press, 1992:59-83.